LabVantage Adds an SDMS to the 8.5 Edition of its LIMS Platform
Along with guaranteeing security and control against data loss or modification, the SDMS system works to automatically collect all relevant lab-generated data for use by laboratory staff.
LabVantage Solutions, a laboratory informatics solutions and services provider, announced that its newly released 8.5 edition of its laboratory information management system (LIMS) platform now offers a fully integrated scientific data management system (SDMS).
Along with guaranteeing security and control against data loss or modification, the SDMS system works to automatically collect all relevant lab-generated data for use by laboratory staff, a July 8, 2020 company press release said. The additional functions of the LabVantage SDMS include:
- Capturing externally generated data from instruments, data sources, incoming emails, and other file sources
- Reducing bottlenecks by deploying distributed file collectors
- Using a centralized LIMS-controlled file system, database, or Amazon web service (AWS) cloud for storage
- Finding and linking back to files for rapid access and restoration for further use
- Creating graphical Talend-based parsers to extract and process data.
“During these challenging times, we are especially proud to release LabVantage 8.5, which represents a major advance reflecting our commitment to making the advantages of digital transformation fully accessible to our customers,” said John Heiser, CEO of LabVantage, in the press release. “LabVantage 8.5’s fully integrated SDMS is specifically designed for the LabVantage platform and provides major benefits to laboratory managers, with the aim of making their operations more efficient, productive, and secure. Our user-friendly, all-in-one SDMS offers seamless, continuous data integrity. Importantly, it allows managers to secure all of their data, not just the final results.”
Source: LabVantage
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
